IRA, Drug Pricing, Tech Antitrust, EchoStar: Votes and Verdicts
Failed to add items
Add to Cart failed.
Add to Wish List failed.
Remove from wishlist failed.
Adding to library failed
Follow podcast failed
Unfollow podcast failed
IRA, Drug Pricing, Tech Antitrust, EchoStar: Votes and Verdicts
-
Narrated by:
-
By:
About this listen
The status of the Republicans’ tax-cut bill and the Inflation Reduction Act — with ramifications for hospitals like HCA and Tenet, health insurers like Centene, electric-vehicle makers like Ford and Tesla and solar companies like First Solar — is among the key catalysts BI litigation and policy analysts are watching this week. The team also discussed President Donald Trump’s “Most-Favored Nation” drug-pricing executive order and the status of antitrust trials, specifically DOJ v. Google over search, and FTC v. Meta. We also discussed an FCC inquiry of EchoStar on May 12 asking for comments on whether the agency should reconsider a Sept. 20 decision by its wireless telecommunications bureau to extend the company’s deadlines to complete construction under a series of FCC licenses.
See omnystudio.com/listener for privacy information.